Fiona Jeganathan

Fiona Jeganathan is Head of Screening and Pharmacology at the Alzheimer’s Research UK Drug Discovery Institute (ARUK DDI) at UCL. She holds a BSc (Hons) in Medical Biochemistry and a PhD in Analytical Sciences from King’s College London and has over a decade of experience in translational drug discovery, spanning target validation, hit identification and lead optimisation. Since joining the ARUK DDI in 2016, Fiona has played a key role in developing and expanding the Institute’s screening and pharmacology capabilities. She leads high-throughput screening, assay development and compound profiling strategies across a multidisciplinary drug discovery portfolio, overseeing the design and implementation of robust biochemical, biophysical and functional cell-based screening cascades. Her expertise encompasses molecular pharmacology and enzymology, high-throughput screening, mechanism-of-action studies, compound profiling and biophysical approaches, including SPR and nanoDSF. She works at the